His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk

  • 0Genetics Division, National Cancer Center Research Institute, Tokyo, Japan.

|

|

Summary

This summary is machine-generated.

This study identifies a common missense single nucleotide polymorphism (SNP) in the MTRR gene as a novel risk factor for pancreatic cancer. This finding has functional implications for folate metabolism and genome methylation.

Area Of Science

  • Genetics
  • Cancer Biology
  • Molecular Epidemiology

Background

  • Pancreatic cancer, particularly invasive ductal adenocarcinoma, has a complex genetic predisposition.
  • Gene-environment interactions are crucial in carcinogenesis, but their role in pancreatic cancer is not fully understood.

Purpose Of The Study

  • To investigate the genetic predisposition to sporadic invasive ductal adenocarcinoma of the pancreas.
  • To focus on genes involved in gene-environment interactions relevant to pancreatic cancer development.

Main Methods

  • Genotyping of 227 single nucleotide polymorphisms (SNPs) in 46 genes among 198 cases and 182 controls.
  • Joint analysis of significant SNPs with expanded sample sizes (317 cases vs. 1232 controls).
  • High-density SNP typing, haplotype analysis (702 cases vs. 785 controls), and functional assessment of MTRR gene variants using transfected cells.

Main Results

  • Two SNPs in the methionine synthase reductase (MTRR) gene, rs162049 and rs10380, were significantly associated with pancreatic cancer risk (P < .0018 and P < .0063, respectively).
  • These associations remained significant after multiple testing adjustment and permutation tests.
  • Functional studies revealed that risk haplotypes of MTRR were associated with elevated homocysteine, reduced LINE-1 methylation, and lower MTRR protein expression.

Conclusions

  • A common missense SNP in the MTRR gene is identified as a novel susceptibility factor for pancreatic cancer.
  • The MTRR gene plays a functional role in folate metabolism and influences genome-wide methylation status, contributing to pancreatic cancer risk.

Related Concept Videos